【獨家代理】巨噬細胞清除劑權威-Formumax氯磷酸二鈉脂質體︱靶點科技北京︱科研級解決方案

技術(shù)文章您現(xiàn)在的位置:首頁(yè) > 技術(shù)文章 > 氯膦酸二鈉脂質(zhì)體ClodronateLiposomes清除巨噬細(xì)胞英文介紹

氯膦酸二鈉脂質(zhì)體ClodronateLiposomes清除巨噬細(xì)胞英文介紹

更新時(shí)間:2023-11-04   點(diǎn)擊次數(shù):984次

Why use Clodronate Liposomes?

Macrophages play an important role in the host defense response and the regulation of many biological processes. Their main activity is phagocytosis and the production and release of soluble mediators (such as NO, cytokines, and chemokines).

Methods to manipulate macrophage activity through liposome-encapsulated molecules

*Drugs that interfere with cellular metabolic pathways can be encapsulated in liposomes, to study their effects on macrophages (drug methods).

*Drugs that selectively interfere with signaling pathways in macrophages can be encapsulated in liposomes

However, signal transduction pathways and compounds affecting these pathways are still under investigation. Therefore, so far, the former method is generally used to inhibit macrophage activity by administering liposome-encapsulated bisphosphonate clodronate.

How Do Clodronate Liposomes Induce Apoptosis in Phagocytes?

Once clodronate is encapsulated in liposomes, it can specifically target phagocytes. Liposomes can be quickly recognized and swallowed by macrophages, allowing an effective clodronate concentration threshold to trigger target cell apoptosis. Clodronate encapsulated in liposomes is recognized as a foreign body by phagocytes and is taken into internal vesicles called phagosomes. After phagocytosis, the phagosome fuses with the lysosome containing phospholipase, which destroys the phospholipid bilayer of the liposome, thereby allowing clodronate to be released in the cell. Once clodronate is released in the cytoplasm, aminoacyl-tRNA synthetase will mistakenly identify it as pyrophosphate and will use clodronate to generate the non-hydrolyzable ATP analogue (AppCCl2p). Then, this ATP analog translocates to the mitochondria, where it irreversibly binds to the ATP/ADP translocase, causing blockage of the respiratory chain, leading to changes in mitochondrial function and integrity. These altered mitochondria release molecular signals that will initiate cell apoptosis.

Unencapsulated clodronate cannot pass through the cell membrane to trigger cell death. Since the control liposome does not contain clodronate, the phagocytes will not be killed.





靶點(diǎn)科技(北京)有限公司

靶點(diǎn)科技(北京)有限公司

地址:中關(guān)村生命科學(xué)園北清創(chuàng)意園2-4樓2層

© 2025 版權(quán)所有:靶點(diǎn)科技(北京)有限公司  備案號(hào):京ICP備18027329號(hào)-2  總訪問量:318670  站點(diǎn)地圖  技術(shù)支持:化工儀器網(wǎng)  管理登陸

牙克石市| 文登市| 崇阳县| 昌邑市| 株洲市| 湄潭县| 边坝县| 鄢陵县| 麦盖提县| 濮阳县| 澄江县| 自贡市| 襄汾县| 新建县| 文安县| 菏泽市| 独山县| 横山县| 永善县| 五河县| 宝山区| 宁都县| 焦作市| 桦川县| 西盟| 酉阳| 获嘉县| 滨州市| 三明市| 衡东县| 固原市| 昌乐县| 黄陵县| 饶平县| 禄丰县| 钦州市| 兰溪市| 兴海县| 沁水县| 龙南县| 瓮安县|